NEUROCRINE BIOSCIENCES INC — Operating Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/107aa806-afca-4819-8ae7-75c3508a4f4e/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $619.1M | 2025-01-01 – 2025-12-31 | evidence 0000914475-26-000007 |
| FY 2024 | $570.5M | 2024-01-01 – 2024-12-31 | evidence 0000914475-25-000037 |
| FY 2023 | $250.9M | 2023-01-01 – 2023-12-31 | evidence 0000914475-24-000054 |
| FY 2022 | $249.0M | 2022-01-01 – 2022-12-31 | evidence 0000914475-23-000011 |
| FY 2021 | $102.5M | 2021-01-01 – 2021-12-31 | evidence 0000914475-22-000013 |
| FY 2020 | $163.0M | 2020-01-01 – 2020-12-31 | evidence 0000914475-21-000020 |
| FY 2019 | $72.3M | 2019-01-01 – 2019-12-31 | evidence 0000914475-21-000020 |
| FY 2018 | $36.8M | 2018-01-01 – 2018-12-31 | evidence 0000914475-21-000020 |
| FY 2017 | $-131.4M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-042794 |
| FY 2016 | $-147.4M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-043838 |
| FY 2015 | $-94.2M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-459862 |
| FY 2014 | $-64.4M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-039176 |
| FY 2013 | $-49.7M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-045619 |
| FY 2012 | $1.4M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-045687 |
| FY 2011 | $33.9M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-048679 |
| FY 2010 | $-13.7M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-048679 |
| FY 2009 | $-53.7M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-048679 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NEUROCRINE BIOSCIENCES INC — all facts · Revenue · Net Income